Exendin-(9-39) Acetate
Appetite Regulation
University of Washingtonprotein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Appetite Regulation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Semaglutide Mount Sinai Hospital, Canada | Phase 3 | BB |
TRIPRO-AMYLIN Esbjerg Hospital - University Hospital of Southern Denmark | Phase 2/3 | B |
Calcipotriene University of Yaounde 1 | Phase 1/2 | CCC |
Cissus Quadrangularia University of Yaounde 1 | Phase 1/2 | CCC |
Same molecule, other indications
Exendin-(9-39) Acetate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →